View : 551 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author나득채*
dc.date.accessioned2022-03-29T16:30:59Z-
dc.date.available2022-03-29T16:30:59Z-
dc.date.issued2022*
dc.identifier.issn0003-4932*
dc.identifier.otherOAK-31142*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/260920-
dc.description.abstractObjective:To investigate the molecular characteristics of AGEJ compared with EAC and gastric adenocarcinoma.Summary of Background Data:Classification of AGEJ based on differential molecular characteristics between EAC and gastric adenocarcinoma has been long-standing controversy but rarely conducted due to anatomical ambiguity and epidemiologic difference.Methods:The molecular classification model with Bayesian compound covariate predictor was developed based on differential mRNA expression of EAC (N = 78) and GCFB (N = 102) from the Cancer Genome Atlas (TCGA) cohort. AGEJ/cardia (N = 48) in TCGA cohort and AGEJ/upper third GC (N = 46 pairs) in Seoul National University cohort were classified into the EAC-like or GCFB-like groups whose genomic, transcriptomic, and proteomic characteristics were compared.Results:AGEJ in both cohorts was similarly classified as EAC-like (31.2%) or GCFB-like (68.8%) based on the 400-gene classifier. The GCFB-like group showed significantly activated phosphoinositide 3-kinase-AKT signaling with decreased expression of ERBB2. The EAC-like group presented significantly different alternative splicing including the skipped exon of RPS24, a significantly higher copy number amplification including ERBB2 amplification, and increased protein expression of ERBB2 and EGFR compared with GCFB-like group. High-throughput 3D drug test using independent cell lines revealed that the EAC-like group showed a significantly better response to lapatinib than the GCFB-like group (P = 0.015).Conclusions:AGEJ was the combined entity of the EAC-like and GCFB-like groups with consistently different molecular characteristics in both Seoul National University and TCGA cohorts. The EAC-like group with a high Bayesian compound covariate predictor score could be effectively targeted by dual inhibition of ERBB2 and EGFR. © 2022 Lippincott Williams and Wilkins. All rights reserved.*
dc.languageEnglish*
dc.publisherLippincott Williams and Wilkins*
dc.subjectadenocarcinoma*
dc.subjectclassification*
dc.subjectERBB2*
dc.subjectesophagogastric junction*
dc.subjectesophagus*
dc.subjectgenome*
dc.subjectneoplasm*
dc.subjectproteome*
dc.subjectsequencing*
dc.subjectstomach*
dc.subjectTCGA*
dc.subjecttranscriptome*
dc.titleComprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction between Esophageal and Gastric Adenocarcinomas*
dc.typeArticle*
dc.relation.issue4*
dc.relation.volume275*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.startpage706*
dc.relation.lastpage717*
dc.relation.journaltitleAnnals of Surgery*
dc.identifier.doi10.1097/SLA.0000000000004303*
dc.identifier.wosidWOS:000766217800027*
dc.identifier.scopusid2-s2.0-85126072576*
dc.author.googleSuh Y.-S.*
dc.author.googleNa D.*
dc.author.googleLee J.-S.*
dc.author.googleChae J.*
dc.author.googleKim E.*
dc.author.googleJang G.*
dc.author.googleLee J.*
dc.author.googleMin J.*
dc.author.googleOck C.-Y.*
dc.author.googleKong S.-H.*
dc.author.googleGeorge J.*
dc.author.googleZhang C.*
dc.author.googleLee H.-J.*
dc.author.googleKim J.-I.*
dc.author.googleKim S.-J.*
dc.author.googleKim W.H.*
dc.author.googleLee C.*
dc.author.googleYang H.-K.*
dc.contributor.scopusid나득채(37034738100)*
dc.date.modifydate20240318140645*
Appears in Collections:
의료원 > 의료원 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE